Clinical Trials
31 trialsPathos
Sir Mortimer B. Davis - Jewish General Hospital
PROVIDENCE
AbbVie
PROQEM
Leiden University Medical Center
A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations
Bristol-Myers Squibb
CHeMoON
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ProHer
Hoffmann-La Roche
IMPLICATION
Centre Hospitalier Universitaire de Besancon
IMPACTT
Vejle Hospital
Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test
University of Texas at Austin
Quality of Care in Relationship to Aborted Cancer Surgery
Linkoeping University
Needs and Preferences of Patients With Head-neck Cutaneous SCC
Maastricht University Medical Center
PREFER-HMA
Otsuka Australia Pharmaceutical Pty Ltd
PrOVE QUERI Project #1
VA Office of Research and Development
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
Indiana University
MYLENE
iOMEDICO AG
STRONG-CS
Bispebjerg Hospital
Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer
Chinese University of Hong Kong
To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).
King's College London
TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)
Dana-Farber Cancer Institute
A Study of Adjuvant Melanoma Stakeholder Treatment Preferences
Bristol-Myers Squibb
NFCP-2
Norwegian University of Science and Technology
Treatment Preference and Patient Centered Prostate Cancer Care
University of Pennsylvania
Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System
Memorial Sloan Kettering Cancer Center
ODIN-Q
University College, London
The Treatment Preferences of Women Diagnosed With Ovarian Cancer
Duke University
HCC Patient Preferences in Japan
Bayer
Patient Preference Survey for Radiation Oncologists
University of Pittsburgh
PISCES
Novartis
Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening
Boston Medical Center
EPIIC
VA Office of Research and Development
An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy
AstraZeneca